- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.3: 7 residues within 4Å:- Chain B: E.181, L.231, N.232, N.346, V.414, S.415
- Ligands: NAG-NAG.4
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.12: 7 residues within 4Å:- Chain G: E.181, L.231, N.232, N.346, V.414, S.415
- Ligands: NAG-NAG.13
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.21: 7 residues within 4Å:- Chain I: E.181, L.231, N.232, N.346, V.414, S.415
- Ligands: NAG-NAG.22
No protein-ligand interaction detected (PLIP)- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.4: 4 residues within 4Å:- Chain B: L.235, P.261, N.416
- Ligands: NAG-NAG-BMA-MAN.3
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 3 residues within 4Å:- Chain B: Q.263, N.265, S.303
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 3 residues within 4Å:- Chain B: V.144, R.162, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 1 residues within 4Å:- Chain B: N.361
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 3 residues within 4Å:- Chain B: T.341, N.355, S.357
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 1 residues within 4Å:- Chain B: N.271
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 4 residues within 4Å:- Chain G: L.235, P.261, N.416
- Ligands: NAG-NAG-BMA-MAN.12
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 3 residues within 4Å:- Chain G: Q.263, N.265, S.303
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 4 residues within 4Å:- Chain G: V.144, R.162, N.167
- Chain I: R.278
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 1 residues within 4Å:- Chain G: N.361
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 3 residues within 4Å:- Chain G: T.341, N.355, S.357
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 1 residues within 4Å:- Chain G: N.271
No protein-ligand interaction detected (PLIP)NAG-NAG.22: 4 residues within 4Å:- Chain I: L.235, P.261, N.416
- Ligands: NAG-NAG-BMA-MAN.21
No protein-ligand interaction detected (PLIP)NAG-NAG.23: 3 residues within 4Å:- Chain I: Q.263, N.265, S.303
No protein-ligand interaction detected (PLIP)NAG-NAG.24: 4 residues within 4Å:- Chain B: R.278
- Chain I: V.144, R.162, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG.25: 1 residues within 4Å:- Chain I: N.361
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 3 residues within 4Å:- Chain I: T.341, N.355, S.357
No protein-ligand interaction detected (PLIP)NAG-NAG.27: 1 residues within 4Å:- Chain I: N.271
No protein-ligand interaction detected (PLIP)- 21 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.28: 1 residues within 4Å:- Chain A: N.100
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain A: N.107, S.109, E.110
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain A: N.126
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: S.17
- Chain B: E.57, N.58
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain B: N.308
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.324
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: N.246, T.248
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain C: N.100
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain C: N.107, S.109, E.110
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain C: N.126
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain F: N.100
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain F: N.126
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain F: N.107, S.109, E.110
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain C: S.17
- Chain G: E.57, N.58
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain G: N.308
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain G: N.324
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain G: N.246, T.248
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain F: S.17
- Chain I: E.57, N.58
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain I: N.308
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain I: N.324
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain I: N.246, T.248
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escolano, A. et al., Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature (2019)
- Release Date
- 2019-06-12
- Peptides
- RC1 variant of HIV-1 Env glycoprotein gp41: ACF
RC1 variant of HIV-1 Env glycoprotein gp120: BGI
Ab874NHP antibody Fab heavy chain: DHJ
Ab874NHP antibody Fab light chain: EKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CF
FB
BG
GI
ID
DH
HJ
JE
EK
KL
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 21 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escolano, A. et al., Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature (2019)
- Release Date
- 2019-06-12
- Peptides
- RC1 variant of HIV-1 Env glycoprotein gp41: ACF
RC1 variant of HIV-1 Env glycoprotein gp120: BGI
Ab874NHP antibody Fab heavy chain: DHJ
Ab874NHP antibody Fab light chain: EKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CF
FB
BG
GI
ID
DH
HJ
JE
EK
KL
L